AAAAAA

   
Results: 1-13 |
Results: 13
The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment
Authors: Kohorn, EI
Citation: Ei. Kohorn, The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment, INT J GYN C, 11(1), 2001, pp. 73-77
Serum levels of macrophage colony-stimulating factor in trophoblastic disease
Authors: Kohorn, EI Kacinski, BM Stanley, ER
Citation: Ei. Kohorn et al., Serum levels of macrophage colony-stimulating factor in trophoblastic disease, GYNECOL ONC, 80(3), 2001, pp. 383-386
Urethral diverticulum in women
Authors: Kohorn, EI
Citation: Ei. Kohorn, Urethral diverticulum in women, J REPRO MED, 46(5), 2001, pp. 504-504
Urethral diverticulum in women
Authors: Kohorn, EI
Citation: Ei. Kohorn, Urethral diverticulum in women, J REPRO MED, 46(2), 2001, pp. 147-148
Nicked human chorionic gonadotropin in trophoblastic disease
Authors: Kohorn, EI Cole, I
Citation: Ei. Kohorn et I. Cole, Nicked human chorionic gonadotropin in trophoblastic disease, INT J GYN C, 10(4), 2000, pp. 330-335
Phantom metastases in trophoblastic disease
Authors: Kohorn, EI
Citation: Ei. Kohorn, Phantom metastases in trophoblastic disease, INT J GYN C, 10(2), 2000, pp. 115-118
Combining the staging system of the International Federation of Gynecologyand Obstetrics with the scoring system of the World Heath Organization forTrophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society
Authors: Kohorn, EI Goldstein, DP Hancock, BW Kim, SJ Lurain, JR Newlands, E Soper, JT Wong, LC
Citation: Ei. Kohorn et al., Combining the staging system of the International Federation of Gynecologyand Obstetrics with the scoring system of the World Heath Organization forTrophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society, INT J GYN C, 10(1), 2000, pp. 84-88
Measurement of CA-125 in trophoblastic disease
Authors: Kohorn, EI
Citation: Ei. Kohorn, Measurement of CA-125 in trophoblastic disease, GYNECOL ONC, 78(1), 2000, pp. 39-42
Oral contraceptive use and risk of gestational trophoblastic tumors
Authors: Palmer, JR Driscoll, SG Rosenberg, L Berkowitz, RS Lurain, JR Soper, J Twiggs, LB Gershenson, DM Kohorn, EI Berman, M Shapiro, S Rao, RS
Citation: Jr. Palmer et al., Oral contraceptive use and risk of gestational trophoblastic tumors, J NAT CANC, 91(7), 1999, pp. 635-640
How soon is it safe to undertake pregnancy after trophoblastic tumor?
Authors: Kohorn, EI
Citation: Ei. Kohorn, How soon is it safe to undertake pregnancy after trophoblastic tumor?, GYNECOL ONC, 73(3), 1999, pp. 343-344
Adenocarcinoma in situ of the cervix: Management and outcome
Authors: Azodi, M Chambers, SK Rutherford, TJ Kohorn, EI Schwartz, PE Chambers, JT
Citation: M. Azodi et al., Adenocarcinoma in situ of the cervix: Management and outcome, GYNECOL ONC, 73(3), 1999, pp. 348-353
Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival
Authors: Schwartz, PE Rutherford, TJ Chambers, JT Kohorn, EI Thiel, RP
Citation: Pe. Schwartz et al., Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival, GYNECOL ONC, 72(1), 1999, pp. 93-99
A blueprint for academic obstetrics and gynecology
Authors: Kohorn, EI
Citation: Ei. Kohorn, A blueprint for academic obstetrics and gynecology, OBSTET GYN, 93(5), 1999, pp. 796-796
Risultati: 1-13 |